21064 ⎘
Medicinal preparations containing antigens or antibodies; Vertebrate antigens Preparations to induce tolerance to non-self, e.g. prior to transplantation
COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC TOLERANCE
#302Methods for modulating immune responses
#303MTB-C vaccine against asthma
#304Modular nanodevices for smart adaptable vaccines
#305Methods of preventing rejection of transplanted tissue by administering anti-CD40L antibody and dendritic cells loaded with type B peptide
#306Expansion of alloantigen-reactive regulatory T cells
#307UNIVERSAL DONOR-DERIVED TOLEROGENIC CELLS FOR INDUCING NON-SYNGENEIC TRANSPLANTATION TOLERANCE
#308Inflammation inhibiting compounds
#309Alteration of cell membrane for new functions using IL-2 and streptavidin
#310Controlled release formulations for the induction and proliferation of blood cells
#311HLA Class II Deficient Cells, HLA Class I Deficient Cells Capable of Expressing HLA Class II Proteins, and Uses Thereof
#312Immune-modifying nanoparticles for the treatment of inflammatory diseases
#313Erythrocyte-binding therapeutics
#314Tolerogenic synthetic nanocarriers for inducing regulatory B cells
#315Immune Regulation
#316NOVEL PHARMACEUTICAL USE OF BENZOIC ACID DERIVATIVES
#317Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
#318Method for inducing immune tolerance using viable polymer-modified allogeneic leukocytes
#319B7-1-PE40KDEL exotoxin fusion gene-based DNA vaccine and the use thereof
#320Treatment of immune disease by mucosal delivery of antigens using genetically modified Lactococcus
#321Methods for modulating immune responses
#322COMPOSITIONS AND METHODS FOR PRODUCING ADAPTIVE REGULATORY T CELLS
#323Modulation of antigen immunogenicity by deleting epitopes recognized by NKT cells
#324ANTIBODY AND METHODS FOR SELECTIVE INHIBITION OF T-CELL RESPONSES
#325Composition and method for inducing antigen-specific tolerance using IgA
#326Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs
#327Compositions and methods for inducing immune tolerance
#328Use of anti third party central memory T cells for anti-leukemia/lymphoma treatment
#329ILT3 polypeptides and uses thereof
#330Regulatory immune cells with enhanced targeted cell death effect
#331Implantation of a cardiac xenograft from a B4GALNT2KO and GTKO transgenic pig to reduce immunogenicity
#332Porcine CTLA-4 for xenograft-specific immunosuppression
#333Vectors and methods for long-term immune evasion to prolong tranplant viability
#334Materials and Methods for Altering an Immune Response to Exogenous and Endogenous Immunogens, Including Syngeneic and Non-Syngeneic Cells, Tissues or Organs
#335DNA vaccines and methods for the prevention of transplantation rejection
#336TOLEROGENIC SYNTHETIC NANOCARRIERS COUPLED TO CD1D-RESTRICTED ANTIGENS AND METHODS OF USE
#337CONTROLLED RELEASE OF IMMUNOSUPPRESSANTS FROM SYNTHETIC NANOCARRIERS
#338Tolerogenic synthetic nanocarriers for allergy therapy
#339TOLEROGENIC SYNTHETIC NANOCARRIERS FOR REGULATING INNATE IMMUNE RESPONSES
#340Tolerogenic synthetic nanocarriers
#341Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responses
#342TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES
#343TOLEROGENIC SYNTHETIC NANOCARRIER COMPOSITIONS WITH TRANSPLANTABLE GRAFT ANTIGENS AND METHODS OF USE
#344Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells
#345Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
#346Tolerogenic synthetic nanocarriers for inducing regulatory B cells
#347Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
#348Pre-Transplant Accommodated Organs Resistant To Anti-Donor Immunity
#349Methods for modulating inflammatory and/or immune responses
#350Methods for modulating inflammatory and/or immune responses
#351Inhibitors of the PP1/GADD34 Complex for the Treatment of a Condition Requiring an Immunosuppressive Activity
#352Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells
#353Alteration of cell membrane for new functions
#354MULTIMERIC POLYPEPTIDES OF HLA-G INCLUDING AT LEAST TWO ALPHA3 DOMAINS AND PHARMACEUTICAL USES THEREOF
#355Erythrocyte-binding therapeutics
#356HLA-G ALPHA 1 MULTIMERS AND PHARMACEUTICAL USES THEREOF
#357Lipidic Compositions for Induction of Immune Tolerance
#358Multimeric polypeptides of HLA-G including alpha1-alpha3 monomers and pharmaceutical uses thereof
#359Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
#360Molecular Antigen Array
#361Methods for Inducing Mixed Chimerism
#362COMPOSITIONS AND METHODS FOR INDUCTION OF ANTIGEN-SPECIFIC TOLERANCE
#363Recombinantly produced allergens
#364Inflammation inhibiting compounds
#365Erythrocyte-binding therapeutics
#366Methods of preventing rejection of transplanted tissue by administering anti-CD40L antibody and dendritic cells loaded with Hsp60sp peptide
#367Methods and systems for inducing immunologic tolerance to non-self antigens
#368Method of identifying CD4CD25T-cells activated to an antigen which express CD8
#369Vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#370Molecular Antigen Array
#371USE OF ZEBURALINE FOR THE TREATMENT OF AUTOIMMUNE DISEASES OR IMMUNE REJECTION OF TRANSPLANTS
#372Methods for inducing selective apoptosis
#373USE OF ALLOGENEIC CELL LINES TO LOAD ANTIGEN-PRESENTING CELLS TO ELICIT OR ELIMINATE IMMUNE RESPONSES
#374Inducible regulatory T-cell generation for hematopoietic transplants
#375Treating allergy with detoxified heat-labile enterotoxin
#376Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment
#377CCR7 ligand delivery and co-delivery in immunotherapy
#378Methods for the treatment of graft-versus-host disease
#379In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#380In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#381Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof
#382Immunogenic peptides and their use in transplantation
#383Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis
#384Method for the identification and separation of non-regulatory T-cells from a mixture of regulatory T-cells
#385Angiotensin peptide-carrier conjugates and uses thereof
#386NOVEL COMPOSITION OF STEM CELLS FOR TRANSPLANTATION TOLERANCE
#387Pre-transplant accomodated organs resistant to anti-donor immunity
#388Activated T Cells
#389Inhibition of Antigen Presentation with Poorly Catabolized Polymers
#390STRATEGIES TO PREVENT AND/OR TREAT IMMUNIE RESPONSES TO SOLUBLE ALLOFACTORS
#391Immunotherapy and prevention of autoimmune hepatitis
#392INDUCTION OF IMMUNOLOGICAL TOLERANCE
#393Methods for Inducing Mixed Donor-Recipient Chimerism in an Allograft Transplant Recipient
#394In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#395In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#396Canine tumor cell and allogeneic dendritic cell fused vaccine and method for preparing the same
#397HLA peptide therapy
#398Method for suppressing immune system response to transplanted tissue or cells
#399Method for inducing selectively suppressed immune response to transplanted tissue or cells
#400Compositions and methods for producing adaptive regulatory T cells
#401Compositions and methods for modulating immune responses
#402TOLERANCE INDUCTION AND MAINTENANCE IN HEMATOPOIETIC STEM CELL ALLOGRAFTS
#403Porcine CTLA-4 for xenograft-specific immunosuppression
#404TREATMENT OF IMMUNE DISEASE BY MUCOSAL DELIVERY OF ANTIGENTS USING GENETICALLY MODIFIED LACTOBACILLUS
#405Methods of modulating the negative chemotaxis of immune cells
#406Apoptotic cell-mediated transfection of mammalian cells with interfering RNA
#407RESPIRATORY SYNCYTIAL VIRUS RENDERS DENDRITIC CELLS TOLEROGENIC
#408Active antiangiogenic therapy
#409Processes for treating subjects carrying viral infectious agent
#410ANTI-CD8 ANTIBODIES BLOCK PRIMING OF CYTOTOXIC EFFECTORS AND LEAD TO GENERATION OF REGULATORY CD8+ T CELLS
#411Induction of Indoleamine 2,3-Dioxygenase in Dendritic Cells by TLR Ligands and Uses thereof
#412POLYNUCLEOTIDE THERAPY
#413ILT3 and ILT4-related compositions and methods
#414ILT3 polypeptides and uses thereof
#415POLYNUCLEOTIDE THERAPY
#416In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#417Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance
#418Viral vaccine composition, process and methods of use
#419Specific CD4+CD25+ Regulatory T Cells for Haematopoietic Cell Transplantation and Immune Tolerance
#420Inhibition of antigen presentation with poorly catabolized polymers
#421DNA Vaccines And Methods For The Prevention Of Transplantation Rejection
#422Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells
#423Antigen Arrays for Treatment of Allergic Eosinophilic Diseases
#424PROCESS FOR REDUCING EFFECTS OF GRAFT VERSUS HOST DISEASE USING EX VIVO EXPANDED CD4+CD25+ REGULATORY T CELLS
#425Cell Population Having Immunoregulatory Activity, Method for Isolation and Uses
#426Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
#427Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs
#428Alteration of cell membrane with FasL
#429Use of cytokines and mitogens to inhibit graft versus host disease
#430Method to Prevent Graft Rejection Using TGF-Beta to Induce T Suppressor Cells
#431INDUCTION OF IMMUNOLOGICAL TOLERANCE
#432Antigen specific immunosuppression by dendritic cell therapy
#433VACCINE COMPOSITION CONTAINING IRRADIATED OVALBUMIN FOR THE PREVENTION AND TREATMENT OF ALLERGIC DISEASE
#434Phenyl-(4-Phenyl-Pyrimidin-2-Yl)-Amines For Enhancing Immunotolerance
#435Cd4+ Cd25+ T-cells activated to a specific antigen
#436Molecular antigen arrary
#437METHODS AND MATERIALS FOR TREATING INFLAMMATORY CONDITIONS
#438Antiangiogenic active immunotherapy
#439Stimulation of thymus for vaccination development
#440Inhibition of Xenoreactive Antibodies
#441Immune regulation
#442Induction And Maintenance Of Tolerance To Composite Tissue Allografts
#443Chimeric allgraft tolerance induction, monitoring and maintenance
#444Tolerance to Graft Prior to Thymic Reactivation
#445Veto cells effective in preventing graft rejection and devoid of graft versus host potential
#446Compositions and methods for inducing chimerism in a subject
#447Compositions and methods of treatment
#448Antigen arrays for treatment of bone disease
#449Antigen arrays for treatment of allergic eosinophilic diseases
#450Angiotensin peptide-carrier conjugates and uses thereof
#451Molecular antigen array
#452Method for preventing rejection of transplanted tissue
#453Transplant acceptance inducing cells of monocytic origin and their preparation and use
#454Methods of expanding and selecting disease associated T-Cells
#455Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
#456Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells
#457Detoxified TNF and method of preparing
#458Treatment and diagnosis of infertitlity using TGFbeta or activin
#459DNA coding for endo-β-galactosidase
#460Bone marrow stromal cells for immunoprotection of transplanted neural stem cells
#461Allogeneic and xenogeneic transplantation
#462Methods for enhancing engraftment of purified hematopoietic stem cells in allogeneic recipients
#463Immunosuppression
#464Compositions and methods for inducing chimerism in a subject
#465Method and composition for regulating the activity of regulatory t cells
#466Methods of generating antigen-specific CD4+CD25+regulatory T cells, compositions and methods of use
#467Vaccine composition comprising methylated DNA and immunomodulatory motifs
#468Tolerogenic vaccine and method
#469Angiotensin peptide-carrier conjugates and uses thereof
#470Human anti-cancer immunotherapy
#471Process of cell electrofusion
#472Liver stromal cells for prevention and treatment of immune responses in transplantation
#473Tolerizing allografts of pluripotent stem cells
#474Vectors and methods for long-term immune evasion to prolong transplant viability
#475Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
#476Novel therapeutic processes for treating infectious agents using same epitope specific antigens, and useful compositions therefor
#477Novel therapeutic processes for treating cancer with trained or adopted immune cells, and useful compositions therefor
#478Novel therapeutic processes for treating cancer with specific antigens
#479Novel therapeutic processes for treating infectious agents by training or adoptive transfer of immune cells, and useful compositions therefor
#480Novel therapeutic processes for enhancing immunized states of vaccinated subjects
#481Generation of antigen specific T suppressor cells for treatment of rejection
#482Method and composition for regulating activity of regulatory T cells
#483Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance
#484Induction of antigen specific immunologic tolerance
#485Immune regulation
#486Active antiangiogenic therapy
#487Methods of therapy
#488Methods of inducing T-cell non-responsiveness with anti-gp39 24-31 antibodies
#489Therapeutic processes and useful compositions therefor
#490Novel therapeutic vaccination processes, and useful compositions therefor
#491Novel therapeutic processes for establishing or enhancing an immunized state, and compositions useful therefor
#492Generation of hematopoietic chimerism and induction of central tolerance
#493Signal-1/signal-2 bifunctional peptide inhibitors
#494Tolerance induction and maintenance in hematopoietic stem cell allografts
#495Regulating immune response using dendritic cells
#496Propagation of human hepatocytes in non-human animals